Eclipse Enterogenesis

Eclipse Regenesis is a clinical-stage medical technology company focused on developing restorative solutions for Short Bowel Syndrome (SBS) and intestinal failure. The company's primary innovation is the Eclipse XL System, a mechanical distraction enterogenesis device designed to stimulate the body's natural regenerative process to grow new, functional small intestine. By increasing the intestinal surface area, the technology aims to reduce or eliminate the need for total parenteral nutrition (TPN) and improve the quality of life for pediatric and adult patients. Headquartered in California, the company is advancing its platform through clinical trials to address a significant unmet need in gastroenterology.